Medication-assisted treatment, or MAT, is one of the most misunderstood tools in addiction recovery. Some people have been told it is just trading one drug for another. Others have avoided it because they believed real recovery meant getting through withdrawal on willpower alone. Neither of those things is true, and for people dealing with opioid use disorder in particular, those misunderstandings carry serious consequences. MAT is FDA-approved, evidence-based, and recommended by SAMHSA, the CDC, and the American Society of Addiction Medicine as a first-line treatment for opioid addiction. Here is what it actually is, how it works, and how to know whether it might be right for you.

What MAT Actually Is

Medication-assisted treatment combines FDA-approved medications with counseling and behavioral therapy to treat substance use disorders. The medications work by stabilizing brain chemistry, reducing cravings, and blocking the euphoric effects of opioids so that people can engage meaningfully in therapy and rebuild their lives without being destabilized by withdrawal or compulsive drug-seeking behavior.

MAT is most commonly used for opioid use disorder and alcohol use disorder, though research into its applications continues to expand. The treatment is not a substitute for therapy or recovery support. It is designed to work alongside those elements, not replace them. According to SAMHSA, MAT has been shown to improve patient survival, increase retention in treatment, decrease illicit drug use, and reduce criminal activity among people with substance use disorders.

The “assisted” in medication-assisted treatment is worth paying attention to. The medication assists recovery. It does not create it. People in MAT programs still do the work of addressing the psychological, behavioral, and relational aspects of addiction. The medication makes that work possible by giving the brain a stable enough foundation to engage in it.

The Medications Used in MAT

For opioid use disorder, three medications are FDA-approved for use in MAT:

• Buprenorphine (brand names include Suboxone and Subutex) is a partial opioid agonist, meaning it activates opioid receptors in the brain but produces a much weaker effect than full opioids like heroin or oxycodone. It reduces cravings and withdrawal symptoms without producing a significant high. Buprenorphine can be prescribed by certified physicians in outpatient settings, which makes it more accessible than some other options.
• Methadone is a full opioid agonist that also reduces cravings and withdrawal symptoms. It has been used in addiction treatment for decades and has a strong evidence base. Methadone for addiction treatment is dispensed through federally certified opioid treatment programs (OTPs), which require in-person visits, at least initially.
• Naltrexone (brand name Vivitrol) is an opioid antagonist, meaning it blocks opioid receptors entirely. It does not reduce withdrawal symptoms and cannot be started until a person has completed detox, but it eliminates the euphoric effect of opioids if a relapse occurs. It is available as a daily pill or a monthly injection.

For alcohol use disorder, two medications are commonly used in MAT programs:

• Naltrexone reduces the pleasurable effects of alcohol and has been shown to decrease heavy drinking days and support sustained recovery.
• Acamprosate helps stabilize brain chemistry during early recovery and reduces the discomfort associated with abstinence, particularly anxiety and restlessness.

The right medication depends on the substance involved, the individual’s medical history, their living situation, and their recovery goals. A qualified treatment provider evaluates all of these factors before recommending a specific approach.

Addressing the “Trading One Drug for Another” Myth

This is the objection that keeps more people away from effective treatment than almost any other. The idea that taking buprenorphine or methadone is the same as continuing to use drugs misunderstands both the pharmacology of these medications and the definition of recovery.

The medications used in MAT are taken at stable, controlled doses under medical supervision. They do not produce intoxication at therapeutic doses. They do not impair judgment, driving ability, or daily functioning. People on buprenorphine or methadone go to work, raise families, attend school, and rebuild relationships. That is the opposite of what active addiction looks like.

The American Society of Addiction Medicine defines recovery as a process of sustained action addressing the biological, psychological, social, and spiritual aspects of addiction. MAT supports that process. Stigma about MAT, including within some recovery communities, has real costs. Research consistently shows that people who discontinue MAT prematurely face significantly higher rates of relapse and overdose death than those who stay on it as long as clinically indicated.

Who Is a Good Candidate for MAT?

MAT is not the right fit for every person or every substance use disorder, but it is appropriate for a much broader population than many people realize. A qualified treatment provider can conduct a full assessment to determine what combination of approaches makes the most sense.

MAT is commonly recommended for people who:

•  Have a diagnosed opioid use disorder or alcohol use disorder
• Have attempted to stop using without medical support and returned to use
• Are at elevated risk of overdose due to the potency of the substances involved, including fentanyl
• Have co-occurring medical or mental health conditions that complicate withdrawal
•  Are seeking a treatment approach that allows them to remain in their community, maintain employment, and continue daily responsibilities while receiving care

MAT is available in both inpatient and outpatient settings. For many people, especially those with family and work obligations, the ability to access treatment without a residential stay is the difference between pursuing help and not pursuing it at all.

What MAT Looks Like in Practice

Starting MAT typically begins with a comprehensive medical and psychiatric evaluation. The provider assesses the type and severity of the substance use disorder, any co-occurring mental health conditions, medical history, and the patient’s goals for treatment. From there, a treatment plan is developed that includes the appropriate medication, dosing protocol, and the counseling and support services that will run alongside it.

MAT is not a one-size timeline. Some people use MAT medications for a defined period during early recovery and then taper off with medical guidance. Others remain on medications long-term, which is also a clinically valid approach. The goal is sustained recovery and quality of life, not meeting an arbitrary timeline for being medication-free.

Regular check-ins with the treatment team allow for adjustments to the medication dose, changes in the counseling approach, and attention to anything else affecting the person’s recovery. The most effective MAT programs treat the whole person, not just the substance use.

Frequently Asked Questions About MAT

Does insurance cover medication-assisted treatment in Texas?

Most private insurance plans, Medicaid, and Medicare are required to cover MAT under the Mental Health Parity and Addiction Equity Act. Coverage details vary by plan. A treatment provider or admissions team can help verify benefits and identify any out-of-pocket costs before treatment begins.

How long does MAT last?

There is no standard duration. SAMHSA recommends that treatment length be determined by the individual’s clinical needs, not by program rules or arbitrary timelines. Some people complete MAT in months. Others benefit from years of medication support. Stopping MAT prematurely is one of the most common factors in relapse and overdose, which is why this decision should always be made with a treatment provider.

Can I do MAT while working or caring for my family?

Yes. MAT, particularly outpatient buprenorphine treatment, is specifically designed to allow people to maintain their daily responsibilities while receiving care. Many people in MAT programs work full-time, parent actively, and participate in their communities. The medications do not cause impairment at therapeutic doses.

Is MAT available for stimulant addiction like meth or cocaine?

Currently, there are no FDA-approved medications specifically for stimulant use disorder. Research is ongoing and promising, but the evidence base for MAT in this area is not yet as established as it is for opioid and alcohol use disorders. Treatment for stimulant addiction currently relies primarily on behavioral therapy, peer support, and structured recovery programming.

MAT Is a Tool, Not a Shortcut

Recovery looks different for every person. For some, that means abstinence-based treatment from day one. For others, it means using every evidence-based tool available, including medication, to build a stable enough foundation to do the deeper work. Neither path is more legitimate than the other. What matters is that the approach fits the person, is supported by qualified clinical care, and gives them the best realistic chance at a sustained, fulfilling life.

If you or someone you love is considering treatment and has questions about whether MAT might be the right fit, More Than Rehab is here to help. Reach out today for a confidential conversation about your options.